![]() |
|||||||
|
Fusion Protein:MTUS1-ASAH1 |
Fusion Gene and Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: MTUS1-ASAH1 | FusionPDB ID: 55932 | FusionGDB2.0 ID: 55932 | Hgene | Tgene | Gene symbol | MTUS1 | ASAH1 | Gene ID | 57509 | 427 |
Gene name | microtubule associated scaffold protein 1 | N-acylsphingosine amidohydrolase 1 | |
Synonyms | ATBP|ATIP|ATIP3|ICIS|MP44|MTSG1 | AC|ACDase|ASAH|PHP|PHP32|SMAPME | |
Cytomap | 8p22 | 8p22 | |
Type of gene | protein-coding | protein-coding | |
Description | microtubule-associated tumor suppressor 1AT2 receptor-binding proteinAT2 receptor-interacting proteinAT2R binding proteinangiotensin-II type 2 receptor-interacting proteinerythroid differentiation-relatedmicrotubule associated tumor suppressor 1mit | acid ceramidaseN-acylethanolamine hydrolase ASAH1N-acylsphingosine amidohydrolase (acid ceramidase) 1acid CDaseacylsphingosine deacylaseputative 32 kDa heart protein | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9ULD2 Main function of 5'-partner protein: FUNCTION: Cooperates with AGTR2 to inhibit ERK2 activation and cell proliferation. May be required for AGTR2 cell surface expression. Together with PTPN6, induces UBE2V2 expression upon angiotensin-II stimulation. Isoform 1 inhibits breast cancer cell proliferation, delays the progression of mitosis by prolonging metaphase and reduces tumor growth. {ECO:0000269|PubMed:12692079, ECO:0000269|PubMed:19794912}. | Q13510 Main function of 5'-partner protein: FUNCTION: Lysosomal ceramidase that hydrolyzes sphingolipid ceramides into sphingosine and free fatty acids at acidic pH (PubMed:10610716, PubMed:7744740, PubMed:15655246, PubMed:11451951). Ceramides, sphingosine, and its phosphorylated form sphingosine-1-phosphate are bioactive lipids that mediate cellular signaling pathways regulating several biological processes including cell proliferation, apoptosis and differentiation (PubMed:10610716). Has a higher catalytic efficiency towards C12-ceramides versus other ceramides (PubMed:7744740, PubMed:15655246). Also catalyzes the reverse reaction allowing the synthesis of ceramides from fatty acids and sphingosine (PubMed:12764132, PubMed:12815059). For the reverse synthetic reaction, the natural sphingosine D-erythro isomer is more efficiently utilized as a substrate compared to D-erythro-dihydrosphingosine and D-erythro-phytosphingosine, while the fatty acids with chain lengths of 12 or 14 carbons are the most efficiently used (PubMed:12764132). Has also an N-acylethanolamine hydrolase activity (PubMed:15655246). By regulating the levels of ceramides, sphingosine and sphingosine-1-phosphate in the epidermis, mediates the calcium-induced differentiation of epidermal keratinocytes (PubMed:17713573). Also indirectly regulates tumor necrosis factor/TNF-induced apoptosis (By similarity). By regulating the intracellular balance between ceramides and sphingosine, in adrenocortical cells, probably also acts as a regulator of steroidogenesis (PubMed:22261821). {ECO:0000250|UniProtKB:Q9WV54, ECO:0000269|PubMed:10610716, ECO:0000269|PubMed:11451951, ECO:0000269|PubMed:12764132, ECO:0000269|PubMed:12815059, ECO:0000269|PubMed:15655246, ECO:0000269|PubMed:17713573, ECO:0000269|PubMed:22261821, ECO:0000269|PubMed:7744740, ECO:0000303|PubMed:10610716}.; FUNCTION: [Isoform 2]: May directly regulate steroidogenesis by binding the nuclear receptor NR5A1 and negatively regulating its transcriptional activity. {ECO:0000305|PubMed:22927646}. | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000262102, ENST00000381862, ENST00000381869, ENST00000519263, ENST00000297488, ENST00000381861, ENST00000400046, ENST00000518713, ENST00000544260, | ENST00000520051, ENST00000262097, ENST00000314146, ENST00000381733, ENST00000417108, ENST00000520781, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 12 X 13 X 5=780 | 13 X 10 X 8=1040 |
# samples | 15 | 16 | |
** MAII score | log2(15/780*10)=-2.37851162325373 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(16/1040*10)=-2.70043971814109 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Fusion gene context | PubMed: MTUS1 [Title/Abstract] AND ASAH1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Fusion neoantigen context | PubMed: MTUS1 [Title/Abstract] AND ASAH1 [Title/Abstract] AND neoantigen [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | MTUS1(17601113)-ASAH1(17920739), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | MTUS1-ASAH1 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. MTUS1-ASAH1 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. MTUS1-ASAH1 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | ASAH1 | GO:0046512 | sphingosine biosynthetic process | 12815059 |
Tgene | ASAH1 | GO:0046513 | ceramide biosynthetic process | 12764132|12815059 |
Tgene | ASAH1 | GO:0046514 | ceramide catabolic process | 12815059 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:17601113/chr8:17920739) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Amino Acid Sequences |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000519263 | MTUS1 | chr8 | 17601113 | - | ENST00000262097 | ASAH1 | chr8 | 17920739 | - | 4301 | 2461 | 174 | 3191 | 1005 |
ENST00000519263 | MTUS1 | chr8 | 17601113 | - | ENST00000381733 | ASAH1 | chr8 | 17920739 | - | 4300 | 2461 | 174 | 3191 | 1005 |
ENST00000519263 | MTUS1 | chr8 | 17601113 | - | ENST00000417108 | ASAH1 | chr8 | 17920739 | - | 4274 | 2461 | 174 | 3191 | 1005 |
ENST00000519263 | MTUS1 | chr8 | 17601113 | - | ENST00000520781 | ASAH1 | chr8 | 17920739 | - | 4274 | 2461 | 174 | 3191 | 1005 |
ENST00000519263 | MTUS1 | chr8 | 17601113 | - | ENST00000314146 | ASAH1 | chr8 | 17920739 | - | 3528 | 2461 | 174 | 3191 | 1005 |
ENST00000519263 | MTUS1 | chr8 | 17601112 | - | ENST00000262097 | ASAH1 | chr8 | 17920739 | - | 4301 | 2461 | 174 | 3191 | 1005 |
ENST00000519263 | MTUS1 | chr8 | 17601112 | - | ENST00000381733 | ASAH1 | chr8 | 17920739 | - | 4300 | 2461 | 174 | 3191 | 1005 |
ENST00000519263 | MTUS1 | chr8 | 17601112 | - | ENST00000417108 | ASAH1 | chr8 | 17920739 | - | 4274 | 2461 | 174 | 3191 | 1005 |
ENST00000519263 | MTUS1 | chr8 | 17601112 | - | ENST00000520781 | ASAH1 | chr8 | 17920739 | - | 4274 | 2461 | 174 | 3191 | 1005 |
ENST00000519263 | MTUS1 | chr8 | 17601112 | - | ENST00000314146 | ASAH1 | chr8 | 17920739 | - | 3528 | 2461 | 174 | 3191 | 1005 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000519263 | ENST00000262097 | MTUS1 | chr8 | 17601113 | - | ASAH1 | chr8 | 17920739 | - | 0.000168947 | 0.9998311 |
ENST00000519263 | ENST00000381733 | MTUS1 | chr8 | 17601113 | - | ASAH1 | chr8 | 17920739 | - | 0.000169471 | 0.9998305 |
ENST00000519263 | ENST00000417108 | MTUS1 | chr8 | 17601113 | - | ASAH1 | chr8 | 17920739 | - | 0.000164713 | 0.99983525 |
ENST00000519263 | ENST00000520781 | MTUS1 | chr8 | 17601113 | - | ASAH1 | chr8 | 17920739 | - | 0.000164713 | 0.99983525 |
ENST00000519263 | ENST00000314146 | MTUS1 | chr8 | 17601113 | - | ASAH1 | chr8 | 17920739 | - | 0.000313095 | 0.99968696 |
ENST00000519263 | ENST00000262097 | MTUS1 | chr8 | 17601112 | - | ASAH1 | chr8 | 17920739 | - | 0.000168947 | 0.9998311 |
ENST00000519263 | ENST00000381733 | MTUS1 | chr8 | 17601112 | - | ASAH1 | chr8 | 17920739 | - | 0.000169471 | 0.9998305 |
ENST00000519263 | ENST00000417108 | MTUS1 | chr8 | 17601112 | - | ASAH1 | chr8 | 17920739 | - | 0.000164713 | 0.99983525 |
ENST00000519263 | ENST00000520781 | MTUS1 | chr8 | 17601112 | - | ASAH1 | chr8 | 17920739 | - | 0.000164713 | 0.99983525 |
ENST00000519263 | ENST00000314146 | MTUS1 | chr8 | 17601112 | - | ASAH1 | chr8 | 17920739 | - | 0.000313095 | 0.99968696 |
![]() |
Get the fusion protein sequences from here. |
Fusion protein sequence information is available in the fasta format. >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP |
Top |
Fusion Protein Breakpoint Sequences for MTUS1-ASAH1 |
![]() |
Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Length(fusion protein) | BP in fusion protein | Peptide |
MTUS1 | chr8 | 17601112 | ASAH1 | chr8 | 17920739 | 2461 | 762 | AVSPQRIRRVSSSGHLIHGRNMDFGV |
MTUS1 | chr8 | 17601113 | ASAH1 | chr8 | 17920739 | 2461 | 762 | AVSPQRIRRVSSSGHLIHGRNMDFGV |
Top |
Potential FusionNeoAntigen Information of MTUS1-ASAH1 in HLA I |
![]() |
MTUS1-ASAH1_17601112_17920739.msa |
![]() * We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5) |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA I | FusionNeoAntigen peptide | Binding score | Immunogenic score | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B27:04 | RRVSSSGHL | 0.9991 | 0.8029 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B27:05 | RRVSSSGHL | 0.999 | 0.732 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B15:16 | RVSSSGHLI | 0.9499 | 0.6665 | 8 | 17 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A74:09 | SSGHLIHGR | 0.9442 | 0.5923 | 11 | 20 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A74:11 | SSGHLIHGR | 0.9442 | 0.5923 | 11 | 20 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A74:03 | SSGHLIHGR | 0.9442 | 0.5923 | 11 | 20 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A30:08 | RVSSSGHLI | 0.9295 | 0.7299 | 8 | 17 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A32:13 | RVSSSGHLI | 0.8999 | 0.9003 | 8 | 17 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A31:02 | SSGHLIHGR | 0.871 | 0.5747 | 11 | 20 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B13:02 | RVSSSGHLI | 0.0319 | 0.5462 | 8 | 17 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B07:10 | RRVSSSGHL | 0.0257 | 0.6526 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B13:01 | RVSSSGHLI | 0.0224 | 0.7315 | 8 | 17 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A31:06 | SSSGHLIHGR | 0.9689 | 0.5054 | 10 | 20 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A31:02 | SSSGHLIHGR | 0.9563 | 0.6297 | 10 | 20 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B27:14 | RRVSSSGHL | 0.9991 | 0.6437 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-C15:06 | RVSSSGHLI | 0.9907 | 0.9401 | 8 | 17 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-C07:95 | RRVSSSGHL | 0.9905 | 0.6108 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-C07:05 | RRVSSSGHL | 0.9824 | 0.8254 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-C07:27 | RRVSSSGHL | 0.9629 | 0.8577 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A31:01 | SSGHLIHGR | 0.9621 | 0.5224 | 11 | 20 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B27:03 | RRVSSSGHL | 0.9516 | 0.765 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-C07:46 | RRVSSSGHL | 0.8367 | 0.8244 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-C12:16 | RRVSSSGHL | 0.0079 | 0.9568 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A31:01 | SSSGHLIHGR | 0.9828 | 0.5745 | 10 | 20 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B27:10 | RRVSSSGHL | 0.9992 | 0.8877 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B27:08 | RRVSSSGHL | 0.999 | 0.6192 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B27:06 | RRVSSSGHL | 0.9987 | 0.7382 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B27:09 | RRVSSSGHL | 0.9975 | 0.688 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-C07:01 | RRVSSSGHL | 0.9937 | 0.6339 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-C15:02 | RVSSSGHLI | 0.9931 | 0.8372 | 8 | 17 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-C15:05 | RVSSSGHLI | 0.9915 | 0.8771 | 8 | 17 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A32:01 | RVSSSGHLI | 0.9755 | 0.8622 | 8 | 17 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A74:01 | SSGHLIHGR | 0.9442 | 0.5923 | 11 | 20 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-A30:01 | RVSSSGHLI | 0.9328 | 0.8996 | 8 | 17 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-C06:08 | RRVSSSGHL | 0.8028 | 0.9627 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-C07:22 | RRVSSSGHL | 0.7723 | 0.6472 | 7 | 16 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B27:06 | RRVSSSGHLI | 0.9994 | 0.6445 | 7 | 17 |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 | HLA-B27:09 | RRVSSSGHLI | 0.999 | 0.6074 | 7 | 17 |
Top |
Potential FusionNeoAntigen Information of MTUS1-ASAH1 in HLA II |
![]() |
![]() * We used NetMHCIIpan v4.1 (%rank<0.5). |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA II | FusionNeoAntigen peptide | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
Top |
Fusion breakpoint peptide structures of MTUS1-ASAH1 |
![]() * The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA. |
File name | BPseq | Hgene | Tgene | Hchr | Hbp | Tchr | Tbp | AAlen |
3960 | IRRVSSSGHLIHGR | MTUS1 | ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 2461 |
Top |
Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of MTUS1-ASAH1 |
![]() * We used Glide to predict the interaction between HLAs and neoantigens. |
HLA allele | PDB ID | File name | BPseq | Docking score | Glide score |
HLA-B14:02 | 3BVN | 3960 | IRRVSSSGHLIHGR | -6.53507 | -6.53507 |
HLA-A24:02 | 5HGA | 3960 | IRRVSSSGHLIHGR | -6.46398 | -6.46398 |
HLA-B27:05 | 6PYJ | 3960 | IRRVSSSGHLIHGR | -3.42521 | -3.42521 |
Top |
Vaccine Design for the FusionNeoAntigens of MTUS1-ASAH1 |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide sequence | FusionNeoAntigen RNA sequence |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 10 | 20 | SSSGHLIHGR | CCAGTTCTGGTCATCTAATACATGGGAGAA |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 11 | 20 | SSGHLIHGR | GTTCTGGTCATCTAATACATGGGAGAA |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 7 | 16 | RRVSSSGHL | GGCGTGTGTCCAGTTCTGGTCATCTAA |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 7 | 17 | RRVSSSGHLI | GGCGTGTGTCCAGTTCTGGTCATCTAATAC |
MTUS1-ASAH1 | chr8 | 17601112 | chr8 | 17920739 | 8 | 17 | RVSSSGHLI | GTGTGTCCAGTTCTGGTCATCTAATAC |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide | FusionNEoAntigen RNA sequence |
Top |
Information of the samples that have these potential fusion neoantigens of MTUS1-ASAH1 |
![]() |
Cancer type | Fusion gene | Hchr | Hbp | Henst | Tchr | Tbp | Tenst | Sample |
STAD | MTUS1-ASAH1 | chr8 | 17601112 | ENST00000519263 | chr8 | 17920739 | ENST00000262097 | TCGA-HU-A4GF |
Top |
Potential target of CAR-T therapy development for MTUS1-ASAH1 |
![]() |
![]() * Minus value of BPloci means that the break point is located before the CDS. |
- In-frame and retained 'Transmembrane'. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
![]() * We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image. |
Hgene | Hchr | Hbp | Henst | Tgene | Tchr | Tbp | Tenst | DeepLoc result |
Top |
Related Drugs to MTUS1-ASAH1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to MTUS1-ASAH1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |